| |
| |
|
| Insider
Information: |
Bechon Christian |
| Relationship: |
Director |
| City: |
Courtaboeuf |
| State: |
I0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
45,826 |
|
|
Indirect Shares
|
2,014,840 |
|
|
| Direct
Value |
$46,444 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,060,666 |
|
|
| Total
Value |
$46,444 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
GTC Biotherapeutics Inc |
GTCB |
Director, 10% Owner |
2009-09-25 |
13,348 |
2009-09-25 |
2,014,840 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
Director |
2023-06-13 |
32,478 |
2019-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,483 |
32,478 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
47,619 |
149,953 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,502 |
102,334 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,390 |
85,832 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Director |
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
11,442 |
61,442 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2009-09-25 |
4 |
A |
$1.76 |
$5,000 |
D/D |
2,844 |
13,348 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2009-06-26 |
4 |
A |
$2.70 |
$5,000 |
D/D |
1,852 |
10,504 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2009-03-27 |
4 |
A |
$0.33 |
$5,000 |
D/D |
15,152 |
86,563 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2008-12-26 |
4 |
A |
$0.28 |
$5,000 |
D/D |
17,953 |
71,411 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2008-09-26 |
4 |
A |
$0.37 |
$5,000 |
D/D |
13,514 |
53,458 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2008-06-27 |
4 |
A |
$0.40 |
$5,000 |
D/D |
12,438 |
39,944 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$5,000 |
D/D |
9,091 |
27,506 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • • |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
I/I |
14,500,000 |
20,148,404 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2008-02-12 |
4 |
B |
$0.87 |
$1,756,011 |
I/I |
2,018,404 |
5,648,404 |
2.1 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-12-28 |
4 |
A |
$0.87 |
$5,000 |
D/D |
5,747 |
18,415 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-09-28 |
4 |
A |
$1.02 |
$5,000 |
D/D |
4,902 |
12,668 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-06-29 |
4 |
A |
$1.15 |
$5,000 |
D/D |
4,348 |
7,766 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,418 |
3,418 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-01-03 |
4 |
B |
$1.23 |
$4,464,900 |
I/I |
3,630,000 |
3,630,000 |
2.1 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
